Dormant
LITE · Lumentum Holdings Inc.
Last analysed ·
Against its published line
Nothing is through its line on this close.
How to read this
The red mark is the published kill line — the price that would prove the pick wrong. The dot is where the name closed on 2 September 2026; a dot LEFT of the mark has closed through its line.
Distance is drawn on a square-root scale, so close calls get the room. Past 8% a row stops competing and reads well clear, with a hollow dot to say the figure is off the drawn scale. Rows run tightest first.
Resolved Graded and closed 2026-09-11 at low conviction — the published kill line did not fire. Coverage continued after the close; the read below is dated 2026-09-13 and is not part of the scored record.
Current thesis
Two initiations in two sessions — Evercore ISI $1,100 on 08-31, Deutsche Bank $1,200 on 09-01 — and the tape closed 2026-09-02 at $870.58, still under the $885 weekly-close level and below the 08-31 close of $914.76. The $40 fiscal-2028 earnings-power leg rests on 2026-08-27 conference commentary; 09-09 Citi and 09-10 Wolfe are the last dated company events before an unconfirmed ~11-03 print, leaving a saturated narrative absorbing coverage seats without a new bid.
Kill line
A weekly close below $820 loses the $820.59 lower August shelf and ends the post-print leg; $866.71 is the immediate shelf, and the $885 weekly-close level sits above the 2026-09-02 close of $870.58. Secondary: 09-09 Citi and 09-10 Wolfe passing with no OCS, 1.6T or Cloud Light figure beyond 2026-08-27's.
Pick status
Played out resolved published kill line did not fire How this is scored →Latest analysis and events for LITE —
As of 18 September 2026, the latest FrontierPicks analysis for Lumentum Holdings Inc. (LITE): 21 April 2026: theme list narrowed to Networking & optical only (ai-datacenter-infra + hyperscaler-capex dropped) — co-movement signal, track for saturation confirmation.
Kill line: A weekly close below $820 loses the $820.59 lower August shelf and ends the post-print leg; $866.71 is the immediate shelf, and the $885 weekly-close level sits above the 2026-09-02 close of $870.58. Secondary: 09-09 Citi and 09-10 Wolfe passing with no OCS, 1.6T or Cloud Light figure beyond 2026-08-27's.
Next dated event on file: — catalyst in 1d.
Current Thesis
Lumentum's optical-switch and faster-transceiver expansion supports an earnings-growth case that the next quarterly results must confirm; a weekly close below $820 ends the published price thesis. The operating test is first-quarter fiscal-2027 revenue within the company's $1.225–1.275 billion guidance and adjusted operating margin within 39.5–40.5%, both issued on 2026-08-11. Filed results and guidance.
The September conferences did produce substantive follow-through. At Citi on 2026-09-09, investor-relations executive Kathy Ta repeated management's fiscal-2028 earnings-per-share outlook of $40 and attributed the additional optical circuit switch (OCS) opportunity to more units for its largest customer. That supersedes the prior concern that the figure might not be repeated after 2026-08-27; it remains management's forecast, rather than reported earnings. Citi conference transcript.
The life-cycle assessment is an inference: the narrative is maturing — the 2026-09-11 adjusted close of $927.03 recovered the previously identified $885 weekly threshold and exceeded the 2026-08-31 close of $914.76, weakening the 2026-09-03 saturation assessment. The supplied three-month price change through 2026-09-11 was only 0.6%, so this recovery does not establish sustained acceleration.
Bullish and bearish views on Lumentum Holdings Inc.
The model's bull view on Lumentum Holdings Inc. (LITE), in brief: Quarterly guidance provides a test. The 2026-08-11 release reported fiscal-fourth-quarter revenue of $1.01 billion and guided fiscal-first-quarter adjusted diluted earnings per share to $4.05–4.35. Delivery within the revenue and margin ranges would support the near-term… The bear view: Customer dependence underlies earnings upside. Both cases follow in full.
Bull Case
- Quarterly guidance provides a test. The 2026-08-11 release reported fiscal-fourth-quarter revenue of $1.01 billion and guided fiscal-first-quarter adjusted diluted earnings per share to $4.05–4.35. Delivery within the revenue and margin ranges would support the near-term earnings case; results below either range would contradict it. Filed release.
- Switch revenue has a benchmark. At the 2026-08-27 Deutsche Bank conference, management said OCS shipments doubled sequentially and expected quarterly OCS revenue above $100 million next quarter. A disclosed result at or below $100 million would fail that specific growth test.
- Pricing supports the margin argument. At Citi on 2026-09-09, business-unit president Wupen Yuen said new deals carried pricing equal to or above previously increased prices. Subsequent disclosure of lower comparable pricing would contradict this support for margins. Citi transcript.
Bear Case
- Customer dependence underlies earnings upside. Ta's 2026-09-09 explanation tied the additional OCS opportunity to the largest customer. A disclosed reduction or delay in that customer's switch requirements would undermine the fiscal-2028 earnings argument. Citi transcript.
- Coverage already spans several formats. Benzinga carried Deutsche Bank's $1,200 initiation on 2026-09-01, a historical-return retrospective on 2026-09-03 and an options-activity headline on 2026-09-09. These are observable attention events; the supplied headlines do not identify net purchases, retail participation or the direction of the options activity.
- Recovery remains below the high. The supplied adjusted series places the 2026-09-11 close of $927.03 at 12.0% below its $1,053.09 trailing-year high. That measures the remaining distance; it supplies no evidence that the high will be recovered.
Setup & Price Structure
The 2026-09-11 close of $927.03 is above both the $885 weekly threshold used in the 2026-09-03 note and the market's 2026-08-31 close of $914.76. The earlier claim that price had failed to recover those levels is therefore stale. The supplied 14-day relative strength index was 55.8 on 2026-09-11; moving-average values and trading-volume comparisons are missing, preventing a measured claim about extension above a rising average or broader participation.
The $885 level remains an intermediate test of the recovery. The published thesis-break threshold remains $820, associated in the 2026-09-03 research with the $820.59 lower August shelf. A weekly close below $820 would invalidate the post-results price structure. These observations support a moderately favorable forecast, while the limited closing-price sample is too small to establish a durable trend.
Catalyst Calendar (next 30 days)
- 2026-09-21–2026-09-23 — European Conference on Optical Communication. Lumentum lists participation in Malaga. Any disclosed product qualification or customer commitment could extend the operating evidence; attendance alone would not confirm the earnings case. Company events calendar.
- 2026-10-12–2026-10-15 — Open Compute Project Global Summit. Lumentum lists the San Jose event, which begins within the next 30 days. A dated deployment announcement could clarify commercialization timing; the listing itself contains no revenue commitment. Company events calendar.
- ~2026-11-03, estimated — Fiscal-first-quarter results. This later event is the operating test on which the thesis turns. The date remains the schedule-derived MarketBeat estimate recorded in the 2026-09-03 coverage, without company confirmation in the reviewed calendar. Revenue, adjusted operating margin and disclosed OCS revenue would test the published benchmarks.
What Would Change Our Mind
Loss of the lower August shelf would break the price structure: a weekly close below $820 ends this thesis even if conference commentary remains favorable. The nearer $885 threshold measures whether the September recovery persists; losing it would weaken the recovery assessment without replacing the published invalidation level.
The near-term operating case would be supported by fiscal-first-quarter revenue of $1.225–1.275 billion, adjusted operating margin of 39.5–40.5% and disclosed OCS revenue above $100 million, matching the 2026-08-11 guidance and 2026-08-27 commentary. Revenue below $1.225 billion or margin below 39.5% would contradict that case. An undisclosed OCS figure would leave the product-specific claim unresolved rather than confirm it.
Correlation Notes
This remains a single-name earnings case with an observed sector response. Benzinga attributed Lumentum's 2026-09-08 advance to optical-connectivity stocks responding to the Corning–Verizon agreement. That attribution supplies a possible explanation for the session, not evidence of a Lumentum customer contract. Benzinga's September 8 report.
The supplied 2026-08-18 and 2026-08-24 reports also described Lumentum weakness around optical-peer earnings and financing news. Those sessions and September 8 are too small a sample to establish a stable correlation. No synchronized return series or measured correlation coefficient is available to support a stronger claim.
Notes
- 2026-04-18: seed: Serenity/attention list
- 2026-04-21: theme list narrowed to Networking & optical only (ai-datacenter-infra + hyperscaler-capex dropped) — co-movement signal, track for saturation confirmation.
- The FQ1 FY27 report date is not company-confirmed; MarketBeat's ~2026-11-03 is schedule-derived. Fiscal 2026 ended 2026-06-27.
- The $40 fiscal-2028 earnings-power figure is verbal management commentary from a 2026-08-27 conference — not formal guidance and not in any filing.
- The FY26 $7.8B convert-equitization charge is non-cash; trailing GAAP EPS and P/E screens stay distorted until it rolls out of the trailing window.
- Insider sales execute under pre-arranged Rule 10b5-1 plans, so Form 4 filing dates carry no discretionary timing signal.
- Institutional ownership was 98.15% on 2026-08-05, so the incremental bid is index- and cohort-driven rather than retail.
- Vendor pages diverge on August-September 2026 closes and on LITE's year-to-date gain; check the series before citing either.
Related · shared themes
ALAB
Astera Labs, Inc.
Q2 (2026-08-04) answered the July margin question: GM 73.7% vs ~73% guide, and Q3 guided $540–560M vs $416.5M consensus (~40% QoQ) with Scorpio X switches in volume production a quarter early. Price has not confirmed — the 2026-08-14 close of $321.61 is ~11% below the post-print level and 33.4% under the $483.02 52-week high.
CRDO
Credo Technology Group Holding Ltd
Interconnect/AEC royalty narrative still accelerating, not fading — new 52-week highs on late-June initiations (Evercore $325, Stifel $350, BofA $340) plus the early-July AI-buildout rally. But it's now mainstream and widely held, entering a ~6-week catalyst void until the late-Aug Q1 FY27 print with macro tightening; continuation intact, though chasing all-time highs here is lower-edge than a pullback to support.
KEYS
Keysight Technologies, Inc.
Analyst-migration re-rate's second leg (Morgan Stanley to Overweight, PT $400, 2026-07-13) has stalled — silent tape near 28x forward, empty calendar until the ~2026-08-19 Q3 FY26 print. The $290–300 breakout-shelf entry hasn't come; current levels buy the tail. Theme accelerating, the KEYS expression maturing.
KOPN
Kopin Corporation
Kopin Corporation's defense orders and optical-interconnect pivot support a recovery case toward the $6.39 market high recorded as of 2026-09-18. The forecast succeeds if that high is reached by the next quarterly report, estimated for 2026-11-10, before a weekly close below $4.00 invalidates it.